1. Stocks
  2. Compass Therapeutics Inc
  3. Swot
swot-logo

Compass Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Compass Therapeutics Inc has 10 Strengths, 10 Weaknesses, 5 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Rising Net Cash Flow and Cash from Operating activity

Relative Outperformance versus Industry over the Quarter (3 Months)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Company with Low Debt

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Stock with Low PE (PE < = 10)

Highest Recovery from 52 Week Low

Stocks Outperforming their Industry Price Change in the Quarter

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Top Losers

Low Piotroski Score : Companies with weak financials

Annual net profit declining for last 2 years

Weak performer : Stock lost more than 20% in 1 month

RSI indicating price weakness

Top Losers

Mutual Funds Increased Shareholding in Past Month

Institutions increasing their shareholding

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks